AU2020265812B2 — Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
Assigned to Trigone Pharma Ltd · Expires 2025-08-28 · 1y expired
What this patent protects
Polymeric liquid formulations for instillation into the bladder or kidney for prolonged release of an active agent and methods of treatment using the formulations are described. When in contact with urine, the formulation forms a mass in the bladder or kidney. The mass entraps th…
USPTO Abstract
Polymeric liquid formulations for instillation into the bladder or kidney for prolonged release of an active agent and methods of treatment using the formulations are described. When in contact with urine, the formulation forms a mass in the bladder or kidney. The mass entraps the active agents and provides prolonged release of the active agents.
Drugs covered by this patent
- Mitozytrex (MITOMYCIN) · Kyowa Kirin Co., Ltd.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.